Abstract
The key regular functions of microRNAs (miRNAs) were only discovered a few years ago, when it became evident that miRNAs play important roles in gene regulation. Today, more than 700 miRNAs have been identified from the human genome. Because of their regulatory functions in transcription, signal transduction, cell cycle regulation, proliferation, cell growth, apoptosis, cell metabolism and neurogenesis, malfunctioning miRNAs have been suggested to affect a number of diseases. Indeed, absence of miRNAs or their mutations has been associated with various types of cancers and other diseases such as neurodegenerative, autoimmune, cardiovascular, infectious, metabolic and oncologic diseases. This has been confirmed by genetic analysis of patient samples. The disease association has attracted potential diagnostic and therapeutic applications of miRNAs. A significant issue to achieve successful therapy is the delivery of miRNAs as problems of targeted and long-lasting presence of miRNA exist. Different approaches have included the modification of miRNAs and the use of viral delivery vectors.
Keywords: Gene regulation, miRNAs as diagnostics, therapeutic miRNAs, delivery of miRNAs
Current Drug Discovery Technologies
Title: Micro-RNA in Disease and Gene Therapy
Volume: 8 Issue: 2
Author(s): Kenneth Lundstrom
Affiliation:
Keywords: Gene regulation, miRNAs as diagnostics, therapeutic miRNAs, delivery of miRNAs
Abstract: The key regular functions of microRNAs (miRNAs) were only discovered a few years ago, when it became evident that miRNAs play important roles in gene regulation. Today, more than 700 miRNAs have been identified from the human genome. Because of their regulatory functions in transcription, signal transduction, cell cycle regulation, proliferation, cell growth, apoptosis, cell metabolism and neurogenesis, malfunctioning miRNAs have been suggested to affect a number of diseases. Indeed, absence of miRNAs or their mutations has been associated with various types of cancers and other diseases such as neurodegenerative, autoimmune, cardiovascular, infectious, metabolic and oncologic diseases. This has been confirmed by genetic analysis of patient samples. The disease association has attracted potential diagnostic and therapeutic applications of miRNAs. A significant issue to achieve successful therapy is the delivery of miRNAs as problems of targeted and long-lasting presence of miRNA exist. Different approaches have included the modification of miRNAs and the use of viral delivery vectors.
Export Options
About this article
Cite this article as:
Lundstrom Kenneth, Micro-RNA in Disease and Gene Therapy, Current Drug Discovery Technologies 2011; 8 (2) . https://dx.doi.org/10.2174/157016311795563857
DOI https://dx.doi.org/10.2174/157016311795563857 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
How Cardiomyocytes Make the Heart Old
Current Pharmaceutical Biotechnology Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19
Current Cardiology Reviews Aldose Reductase: A Novel Target for Cardioprotective Interventions
Current Drug Targets The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art
Current Radiopharmaceuticals mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Relationship Between Hypertension and Atherosclerosis: From a Viewpoint of the Most Potent Vasoconstrictor Human Urotensin II
Current Hypertension Reviews Stem Cell Pharmacogenomics
Current Topics in Medicinal Chemistry Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
Current Neuropharmacology Effects of Apelin Peptides on Diabetic Complications
Current Protein & Peptide Science Editorial (Heart Failure: The Need for Global Health Perspective)
Current Cardiology Reviews Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
Current Vascular Pharmacology Natural Products to Anti-trypanosomal Drugs: An Overview of New Drug Prototypes for American Trypanosomiasis
Cardiovascular & Hematological Agents in Medicinal Chemistry Statins and Inflammation in Cardiovascular Disease
Current Pharmaceutical Design Application of G-CSF in Congestive Heart Failure Treatment
Current Cardiology Reviews Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease
Current Drug Targets Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients?
Current Pharmaceutical Design Puerarin: A Review on the Pharmacological Activity, Chemical Properties and Pharmacokinetics of Main Isoflavonoid
The Natural Products Journal Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
Current Cardiology Reviews MicroRNAs and Cardiac Conduction
Current Drug Targets Tissue Engineering Techniques in Cardiac Repair and Disease Modelling
Current Pharmaceutical Design